@SARS-CoV-2

The University of Cambridge and spinout company DIOSynVax have successfully tested the first AI-designed universal coronavirus vaccine in humans, finding it safe and well-tolerated in a 39-volunteer t…

The University of Cambridge successfully tested a vaccine with an antigen designed entirely by artificial intelligence, marking the first time a computer-designed active component has been used in hum…